|
CL2025003637A1
(es)
|
|
Anticuerpos anti-tgf-beta 1 latente y métodos de uso.
|
|
CA3240172A1
(https=)
|
|
|
|
BR102023005164A2
(https=)
|
|
|
|
BR202022009269U2
(https=)
|
|
|
|
BR202022001779U2
(https=)
|
|
|
|
BR202022000931U2
(https=)
|
|
|
|
CN307047350S
(https=)
|
|
|
|
CN307046557S
(https=)
|
|
|
|
CN307049953S
(https=)
|
|
|
|
CN307049847S
(https=)
|
|
|
|
BY13153U
(https=)
|
|
|
|
CN307049823S
(https=)
|
|
|
|
CN307049665S
(https=)
|
|
|
|
BY13152U
(https=)
|
|
|
|
BY13151U
(https=)
|
|
|
|
BY13150U
(https=)
|
|
|
|
CN307049515S
(https=)
|
|
|
|
BY13145U
(https=)
|
|
|
|
CN307049017S
(https=)
|
|
|
|
BY13144U
(https=)
|
|
|
|
CN307049008S
(https=)
|
|
|
|
CN307048274S
(https=)
|
|
|
|
CN307047404S
(https=)
|
|
|
|
CN307047382S
(https=)
|
|
|
|
BY13172U
(https=)
|
|
|